Stockscreener 앱 받기
3.75
5.93%
0.21
시간 외 거래:
3.74
-0.010
-0.27%
Recursion Pharmaceuticals Inc 주식(RXRX)의 최신 뉴스
Recursion CEO outlines AI drug discovery strategy in Morgan Stanley webcast - Investing.com Canada
Recursion Pharmaceuticals Inc. (RXRX) partners with Citeline to develop AI-powered ClinTech platform - MSN
Recursion Pharmaceuticals (RXRX) down 16.5% since last earnings report: Can it rebound? - MSN
Recursion Pharmaceuticals Stock (RXRX) Opinions on Upcoming Earnings and AI Developments - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
Recursion And Citeline Deepen AI Trial Data Tie For RXRX Investors - Yahoo Finance
Why Recursion (RXRX) Is Up 10.8% After Deepening Citeline Partnership To Power AI-Driven Clinical Trials - Sahm
Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
RXRX|Recursion Pharmaceuticals Inc|Price:3.369|Chg%:0.09 - TradingKey
Recursion Pharmaceuticals (RXRX) stock declines while market improves: Some information for investors - MSN
Recursion Pharmaceuticals, Inc. (RXRX) stock price, news, quote and history - Yahoo Finance UK
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Insider Sell Alert: Blake Borgeson Sells 30,000 Shares of Recurs - GuruFocus
Recursion names Vicki Goodman as CMO - MSN
Recursion to Participate in Upcoming Investor Conferences - marketscreener.com
Recursion Pharmaceuticals Inc. (RXRX) Partners with Citeline to Develop AI-Powered ClinTech Platform - Insider Monkey
Fund Flows: Is Recursion Pharmaceuticals Inc forming a double bottom2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Recursion Pharmaceuticals, Inc. (RXRX) latest stock news and headlines - au.finance.yahoo.com
Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)? - Sahm
Recursion Pharmaceuticals (RXRX) beats stock market upswing: What investors need to know - MSN
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Director at Recursion (NASDAQ: RXRX) awarded 3,268 shares - Stock Titan
Expanded Citeline Data Partnership and CMO Transition Could Be A Game Changer For Recursion Pharmaceuticals (RXRX) - Yahoo Finance
A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge - Sahm
1 Beaten-Down AI Stock to Buy and 1 to Avoid - Yahoo Finance
Citeline expands partnership with Recursion for clinical trials - investing.com
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - GlobeNewswire Inc.
2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail
RXRX Stock Price, Quote & Chart | RECURSION PHARMACEUTICALS-A (NASDAQ:RXRX) - ChartMill
RXRX SEC FilingsRecursion Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - MSN
Recursion Pharmaceuticals (NASDAQ:RXRX) Rating Lowered to Sell at Wall Street Zen - MarketBeat
2.69%
0.25%
자본화:
|
볼륨(24시간):